The Immune Checkpoints CTLA-4 and PD-L1 in Carcinomas of the Uterine Cervix
ConclusionCTLA-4 and PD-L1 are potential therapeutic targets in cervical cancer.
Source: Pathology Research and Practice - Category: Pathology Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Cancer of the Uterus | Carcinoma | Cervical Cancer | Georgia Health | Pathology | Squamous Cell Carcinoma